Hernández-Molina J M, Llosá J, Martínez-Brocal A, de la Rosa M
Servicio de Microbiología, Hospital Virgen de las Nieves, Granada.
Enferm Infecc Microbiol Clin. 1991 Aug-Sep;9(7):405-8.
We studied the in vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole and ciclopirox, as well other classical antifungal agents against 188 Candida spp. strains. Minimum inhibitory concentrations (MIC) have been determined by dilution-agar technique. Of all the imidazole compound tested, isoconazole showed the greatest activity against 186 Candida strains isolates (MIC 90%: 4 micrograms/ml). Sulconazole and cloconazole showed their best activity against 106 Candida albicans isolates. Butoconazole and isoconazole had demonstrated good activity against C. albicans and also were the most active agents against 80 Candida spp. isolates. In vitro activity of ciclopirox against Candida is close to that of econazole (MIC 90%: 8 micrograms/ml).
我们研究了氯康唑、舒康唑、布康唑、异康唑、芬替康唑和环吡酮以及其他经典抗真菌药物对188株念珠菌属菌株的体外活性。最低抑菌浓度(MIC)通过稀释琼脂技术测定。在所有测试的咪唑化合物中,异康唑对186株念珠菌分离株显示出最大活性(MIC 90%:4微克/毫升)。舒康唑和氯康唑对106株白色念珠菌分离株显示出最佳活性。布康唑和异康唑对白色念珠菌显示出良好活性,并且也是对80株念珠菌属分离株最具活性的药物。环吡酮对念珠菌的体外活性与益康唑相近(MIC 90%:8微克/毫升)。